COMP <GO>
ARVN vs JNJ // ENTERPRISE SCALE & MARKET CAP
Arvinas Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: ARVN 0
— JNJ 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: JNJ
LAST: $7.90 (+3.95%) • MKT CAP: $516.6M
market-cap
$516.6M
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
market-cap
$662.49B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARVN VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARVN | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.10% | 25.50% | -57.60 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.97% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -45.10% | 34.70% | -79.80 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -30.80% | 28.50% | -59.30 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | -0.30% | 6.00% | -6.30 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.59 | -5.39 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.3 | 62.1 | -6.80 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $516.6M | $662.49B | -$661.98B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARVN REV | JNJ REV | ARVN GROSS % | JNJ GROSS % | ARVN FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $262.6M | $94.19B | — | 67.9% | -$275.7M | $19.70B |
| FY 2024 | $263.4M | $88.82B | — | 69.1% | -$261.1M | $19.84B |
| FY 2023 | $78.5M | $85.16B | — | — | -$347.8M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARVN // BETA —
JNJ // BETA 1.08